naringenin has been researched along with Condition, Preneoplastic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahmad Ganaie, M; Ahmad, B; Ali, R; Bilal Ahmad, S; Farooq, A; Hussain, I; Madkhali, H; Masoodi, M; Muzamil, S; Rahman Mir, MU; Rashid, SM; Rehman, MU | 1 |
1 other study(ies) available for naringenin and Condition, Preneoplastic
Article | Year |
---|---|
Naringenin (4,5,7-trihydroxyflavanone) suppresses the development of precancerous lesions via controlling hyperproliferation and inflammation in the colon of Wistar rats.
Topics: Aberrant Crypt Foci; Animals; Anticarcinogenic Agents; Carcinogenesis; Cell Proliferation; Colonic Neoplasms; Flavanones; Inflammation; Lipid Peroxidation; Male; Mucins; NF-kappa B; Oxidative Stress; Precancerous Conditions; Rats, Wistar; Tumor Necrosis Factor-alpha | 2018 |